Concepts (114)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Vasodilation | 6 | 2022 | 65 | 2.060 |
Why?
|
| Mesenteric Arteries | 5 | 2022 | 20 | 2.050 |
Why?
|
| Receptors, Calcium-Sensing | 6 | 2019 | 14 | 1.620 |
Why?
|
| Calcium | 5 | 2019 | 480 | 1.510 |
Why?
|
| Calcium Signaling | 5 | 2015 | 101 | 1.330 |
Why?
|
| Protein Kinase C-alpha | 2 | 2015 | 10 | 0.820 |
Why?
|
| Extracellular Space | 1 | 2019 | 35 | 0.680 |
Why?
|
| Down-Regulation | 2 | 2019 | 435 | 0.680 |
Why?
|
| Protein Kinase C | 1 | 2019 | 120 | 0.640 |
Why?
|
| Arachidonic Acids | 2 | 2008 | 24 | 0.580 |
Why?
|
| Pertussis Toxin | 1 | 2015 | 27 | 0.520 |
Why?
|
| Hypertension | 1 | 2022 | 796 | 0.500 |
Why?
|
| Neuroblastoma | 1 | 2015 | 129 | 0.490 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2013 | 67 | 0.440 |
Why?
|
| Nitric Oxide Synthase Type I | 1 | 2013 | 56 | 0.440 |
Why?
|
| Sensory Receptor Cells | 2 | 2015 | 32 | 0.430 |
Why?
|
| Nerve Net | 1 | 2013 | 76 | 0.430 |
Why?
|
| Rats | 7 | 2022 | 3483 | 0.420 |
Why?
|
| Myography | 1 | 2011 | 2 | 0.410 |
Why?
|
| Rats, Inbred Dahl | 2 | 2022 | 33 | 0.380 |
Why?
|
| Nitric Oxide | 1 | 2013 | 316 | 0.370 |
Why?
|
| Endocannabinoids | 2 | 2008 | 39 | 0.330 |
Why?
|
| Glycerides | 1 | 2008 | 10 | 0.320 |
Why?
|
| Dental Pulp | 1 | 2008 | 3 | 0.310 |
Why?
|
| Trigeminal Ganglion | 1 | 2008 | 13 | 0.310 |
Why?
|
| Tooth | 1 | 2008 | 12 | 0.310 |
Why?
|
| Cytochrome P-450 Enzyme System | 1 | 2008 | 92 | 0.300 |
Why?
|
| Animals | 11 | 2022 | 15081 | 0.300 |
Why?
|
| Axons | 1 | 2008 | 108 | 0.290 |
Why?
|
| Ganglia, Spinal | 1 | 2007 | 37 | 0.290 |
Why?
|
| Cardiovascular Physiological Phenomena | 1 | 2005 | 10 | 0.260 |
Why?
|
| Signal Transduction | 2 | 2019 | 1908 | 0.260 |
Why?
|
| Rats, Wistar | 3 | 2011 | 233 | 0.240 |
Why?
|
| Receptors, Steroid | 2 | 2014 | 36 | 0.230 |
Why?
|
| Protein Kinase Inhibitors | 2 | 2019 | 122 | 0.230 |
Why?
|
| Vasoconstriction | 2 | 2013 | 42 | 0.210 |
Why?
|
| Sodium Chloride, Dietary | 1 | 2022 | 41 | 0.200 |
Why?
|
| Vasoconstrictor Agents | 2 | 2013 | 41 | 0.190 |
Why?
|
| Vasodilator Agents | 2 | 2013 | 56 | 0.190 |
Why?
|
| Calcium Channel Blockers | 2 | 2013 | 56 | 0.190 |
Why?
|
| Phosphorylation | 2 | 2015 | 928 | 0.160 |
Why?
|
| Enzyme Inhibitors | 2 | 2013 | 433 | 0.160 |
Why?
|
| Cells, Cultured | 2 | 2015 | 1518 | 0.150 |
Why?
|
| Obesity | 2 | 2014 | 1067 | 0.130 |
Why?
|
| Mice, Knockout | 2 | 2013 | 933 | 0.110 |
Why?
|
| Dietary Fats | 1 | 2014 | 119 | 0.110 |
Why?
|
| RNA, Messenger | 2 | 2008 | 1207 | 0.110 |
Why?
|
| Glucose | 1 | 2013 | 230 | 0.100 |
Why?
|
| Nerve Tissue Proteins | 1 | 2013 | 360 | 0.090 |
Why?
|
| Up-Regulation | 1 | 2013 | 513 | 0.090 |
Why?
|
| Nerve Endings | 1 | 2010 | 8 | 0.090 |
Why?
|
| Neocortex | 1 | 2010 | 27 | 0.090 |
Why?
|
| Mice | 4 | 2014 | 5913 | 0.090 |
Why?
|
| Presynaptic Terminals | 1 | 2010 | 53 | 0.090 |
Why?
|
| Cell Line, Tumor | 1 | 2015 | 2231 | 0.080 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2010 | 1039 | 0.080 |
Why?
|
| Quinacrine | 1 | 2008 | 5 | 0.080 |
Why?
|
| Miconazole | 1 | 2008 | 4 | 0.080 |
Why?
|
| 8,11,14-Eicosatrienoic Acid | 1 | 2008 | 4 | 0.080 |
Why?
|
| Phospholipases A2 | 1 | 2008 | 9 | 0.080 |
Why?
|
| Lipoprotein Lipase | 1 | 2008 | 5 | 0.080 |
Why?
|
| Potassium Channels, Calcium-Activated | 1 | 2008 | 8 | 0.080 |
Why?
|
| Phenylephrine | 1 | 2008 | 36 | 0.080 |
Why?
|
| Potassium Channel Blockers | 1 | 2008 | 33 | 0.080 |
Why?
|
| Mice, Inbred C57BL | 1 | 2013 | 1609 | 0.080 |
Why?
|
| Laser-Doppler Flowmetry | 1 | 2008 | 10 | 0.080 |
Why?
|
| Arterioles | 1 | 2008 | 19 | 0.080 |
Why?
|
| Regional Blood Flow | 1 | 2008 | 40 | 0.080 |
Why?
|
| Calcification, Physiologic | 1 | 2008 | 13 | 0.080 |
Why?
|
| Acetylcholine | 1 | 2008 | 73 | 0.080 |
Why?
|
| Receptor, Cannabinoid, CB1 | 1 | 2008 | 40 | 0.080 |
Why?
|
| Piperidines | 1 | 2008 | 77 | 0.080 |
Why?
|
| Pyrazoles | 1 | 2008 | 85 | 0.080 |
Why?
|
| Enzyme Activators | 1 | 2007 | 12 | 0.070 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 2007 | 41 | 0.070 |
Why?
|
| Aniline Compounds | 1 | 2007 | 23 | 0.070 |
Why?
|
| Gadolinium | 1 | 2007 | 27 | 0.070 |
Why?
|
| Cell Line | 2 | 2010 | 1354 | 0.070 |
Why?
|
| Green Fluorescent Proteins | 1 | 2007 | 208 | 0.070 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2007 | 295 | 0.070 |
Why?
|
| Polyunsaturated Alkamides | 1 | 2005 | 15 | 0.070 |
Why?
|
| Transfection | 1 | 2007 | 523 | 0.070 |
Why?
|
| Peptides | 1 | 2008 | 320 | 0.060 |
Why?
|
| Male | 5 | 2014 | 20025 | 0.060 |
Why?
|
| Humans | 5 | 2015 | 37093 | 0.050 |
Why?
|
| Time Factors | 1 | 2007 | 1742 | 0.050 |
Why?
|
| Liver | 2 | 2014 | 479 | 0.050 |
Why?
|
| Cytochrome P-450 CYP3A | 1 | 2014 | 24 | 0.030 |
Why?
|
| Adipose Tissue, White | 1 | 2014 | 14 | 0.030 |
Why?
|
| Glucokinase | 1 | 2013 | 3 | 0.030 |
Why?
|
| Hepatomegaly | 1 | 2013 | 4 | 0.030 |
Why?
|
| Carnitine O-Palmitoyltransferase | 1 | 2013 | 6 | 0.030 |
Why?
|
| Hyperinsulinism | 1 | 2013 | 17 | 0.030 |
Why?
|
| Glucose Intolerance | 1 | 2014 | 42 | 0.030 |
Why?
|
| Ion Channels | 1 | 2014 | 71 | 0.030 |
Why?
|
| PPAR alpha | 1 | 2013 | 42 | 0.030 |
Why?
|
| Species Specificity | 1 | 2013 | 245 | 0.030 |
Why?
|
| Mitochondrial Proteins | 1 | 2014 | 107 | 0.030 |
Why?
|
| Adipose Tissue | 1 | 2013 | 177 | 0.030 |
Why?
|
| Blood Glucose | 1 | 2014 | 353 | 0.030 |
Why?
|
| Mice, Transgenic | 1 | 2014 | 617 | 0.030 |
Why?
|
| Membrane Proteins | 1 | 2014 | 517 | 0.020 |
Why?
|
| Glutamates | 1 | 2010 | 22 | 0.020 |
Why?
|
| Allosteric Regulation | 1 | 2010 | 22 | 0.020 |
Why?
|
| Naphthalenes | 1 | 2010 | 38 | 0.020 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 2010 | 79 | 0.020 |
Why?
|
| DNA Primers | 1 | 2010 | 286 | 0.020 |
Why?
|
| Female | 3 | 2014 | 20969 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2014 | 1015 | 0.020 |
Why?
|
| Indoles | 1 | 2010 | 158 | 0.020 |
Why?
|
| Kinetics | 1 | 2010 | 708 | 0.020 |
Why?
|
| Base Sequence | 1 | 2010 | 997 | 0.020 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2013 | 643 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2010 | 1618 | 0.020 |
Why?
|